BETH ISRAEL DEACONESS MEDICAL CENTER
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1896-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.bidmc.org/
Boron Neutron Capture Therapy in Treating Patients With Melanoma
- Conditions
- First Posted Date
- 2003-05-07
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Registration Number
- NCT00059800
- Locations
- ๐บ๐ธ
Massachusetts Institute of Technology, Cambridge, Massachusetts, United States
๐บ๐ธBeth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
- Conditions
- First Posted Date
- 2003-03-07
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT00055614
- Locations
- ๐บ๐ธ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Registration Number
- NCT00039572
- Locations
- ๐บ๐ธ
Massachusetts Institute of Technology, Cambridge, Massachusetts, United States
๐บ๐ธBeth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Registration Number
- NCT00003741
- Locations
- ๐บ๐ธ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-08-13
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT00004081
- Locations
- ๐บ๐ธ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Registration Number
- NCT00052416
- Locations
- ๐บ๐ธ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
๐บ๐ธFletcher Allen Health Care - University Health Center Campus, Burlington, Vermont, United States
Progesterone vs Placebo Therapy for Women With Epilepsy
- Conditions
- Interventions
- First Posted Date
- 2002-01-16
- Last Posted Date
- 2017-06-05
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 294
- Registration Number
- NCT00029536
- Locations
- ๐บ๐ธ
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
๐บ๐ธUniversity of Virginia, Charlottesville, Virginia, United States
๐บ๐ธColumbia Medical Center, New York, New York, United States
Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance
- Conditions
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 18
- Registration Number
- NCT00004419
- Locations
- ๐บ๐ธ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States